Infallible Pharma Private Limited, a active private limited company, was established on 20 March 2019 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304MH2019PTC322834. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.44 Cr.
Employing 69 professional, Its leadership includes Shreekant Krishna Shetty (Whole-Time Director), Hari Om (Managing Director), Hari Krishnababu Naidu (Additional Director). Past directors included Bharat Harsukhlal Shah, Shreekant Krishna Shetty, Ramashankar Mehadia. It holds ₹36.95 Cr open charges and ₹8.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 202,2Nd Floor, Matru Smruti Building, Lokmanylak Road No. 02,Dadar East,, Mumbai, Maharashtra, 400014.
U24304MH2019PTC322834
322834
20 March 2019
₹5.00 Cr
₹2.44 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Infallible Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shreekant Krishna Shetty | Whole-Time Director | 01 Sep 2019 | Current |
| Hari Om | Managing Director | 20 Mar 2019 | Current |
| Hari Krishnababu Naidu | Additional Director | 16 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 07 Jul 2022 | Past |
| Pramod Abcsdd | Director | 23 Mar 2021 | Past |
| Pramod Abcsdd | Director | 01 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Infallible Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.8% decrease. The company also saw a substantial fall in profitability, with a 99.69% decrease in profit. The company's net worth dipped by a decrease of 0.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Infallible Pharma had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹369,500,000.00
₹80,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2024 | Others | ₹8.00 Cr | Open |
| 24 Nov 2023 | Others | ₹7.50 Cr | Open |
| 26 Aug 2021 | Others | ₹21.45 Cr | Open |
| 27 Oct 2022 | Others | ₹8.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Infallible Pharma has a workforce of 69 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Infallible Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infallible Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hari Krishnababu Naidu was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2024 & has been associated with this company since 1 year 6 days . was completed.
Infallible Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100972638 was registered on 21 Aug 2024. was documented.
Progress on A charge with Others of Rs. 21.45 Cr registered on 26 Aug 2021 with Charge ID 100510121 was modified on 21 Aug 2024. was documented.
The activity Infallible Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100829638 was registered on 24 Nov 2023. was recorded as a recent event.
The CIN of Infallible Pharma Private Limited is U24304MH2019PTC322834.
Infallible Pharma Private Limited is headquartered at 202,2Nd Floor, Matru Smruti Building, Lokmanylak Road No. 02,Dadar East,, Mumbai, Maharashtra, 400014.
Infallible Pharma Private Limited was incorporated on 20 March 2019.
The current directors of Infallible Pharma Private Limited are
The primary industry of Infallible Pharma Private Limited is Manufacturing.
Infallible Pharma Private Limited is unlisted.
The authorized capital of Infallible Pharma Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.44 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX